Literature DB >> 31335571

Respiratory Syncytial Virus Vaccines: Are We Making Progress?

Asuncion Mejias1,2,3,4, Rosa Rodriguez-Fernandez1,5, Mark E Peeples1,4, Octavio Ramilo1,2,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31335571     DOI： 10.1097/INF.0000000000002404

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


× No keyword cloud information.
  8 in total

1.  Advanced Live Attenuated Vaccines for the Prevention of Respiratory Syncytial Virus Infections in Young Children.

Authors:  Octavio Ramilo; Rosa Rodriguez-Fernandez; Mark E Peeples; Asuncion Mejias
Journal:  J Infect Dis       Date:  2020-06-16       Impact factor: 5.226

Review 2.  The journey to a respiratory syncytial virus vaccine.

Authors:  Asuncion Mejias; Rosa Rodríguez-Fernández; Silvia Oliva; Mark E Peeples; Octavio Ramilo
Journal:  Ann Allergy Asthma Immunol       Date:  2020-03-23       Impact factor: 6.347

3.  Stable Attenuation of Human Respiratory Syncytial Virus for Live Vaccines by Deletion and Insertion of Amino Acids in the Hinge Region between the mRNA Capping and Methyltransferase Domains of the Large Polymerase Protein.

Authors:  Miaoge Xue; Rongzhang Wang; Olivia Harder; Phylip Chen; Mijia Lu; Hui Cai; Anzhong Li; Xueya Liang; Ryan Jennings; Krista La Perle; Stefan Niewiesk; Mark E Peeples; Jianrong Li
Journal:  J Virol       Date:  2020-11-23       Impact factor: 5.103

4.  Viral RNA N6-methyladenosine modification modulates both innate and adaptive immune responses of human respiratory syncytial virus.

Authors:  Miaoge Xue; Yuexiu Zhang; Haitao Wang; Elizabeth L Kairis; Mijia Lu; Sadeem Ahmad; Zayed Attia; Olivia Harder; Zijie Zhang; Jiangbo Wei; Phylip Chen; Youling Gao; Mark E Peeples; Amit Sharma; Prosper Boyaka; Chuan He; Sun Hur; Stefan Niewiesk; Jianrong Li
Journal:  PLoS Pathog       Date:  2021-12-20       Impact factor: 6.823

5.  Human respiratory syncytial virus diversity and epidemiology among patients hospitalized with severe respiratory illness in South Africa, 2012-2015.

Authors:  Ziyaad Valley-Omar; Stefano Tempia; Orienka Hellferscee; Sibongile Walaza; Ebrahim Variava; Halima Dawood; Kathleen Kahn; Meredith McMorrow; Marthi Pretorius; Senzo Mtshali; Ernest Mamorobela; Nicole Wolter; Marietjie Venter; Anne von Gottberg; Cheryl Cohen; Florette K Treurnicht
Journal:  Influenza Other Respir Viruses       Date:  2021-09-16       Impact factor: 5.606

6.  Role of age and birth month in infants hospitalized with RSV-confirmed disease in the Valencia Region, Spain.

Authors:  Ainara Mira-Iglesias; Clarisse Demont; F Xavier López-Labrador; Beatriz Mengual-Chuliá; Javier García-Rubio; Mario Carballido-Fernández; Miguel Tortajada-Girbés; Juan Mollar-Maseres; Germán Schwarz-Chavarri; Joan Puig-Barberà; Javier Díez-Domingo
Journal:  Influenza Other Respir Viruses       Date:  2021-11-24       Impact factor: 4.380

7.  Role of G2-S16 Polyanionic Carbosilane Dendrimer in the Prevention of Respiratory Syncytial Virus Infection In Vitro and In Vivo in Mice.

Authors:  Ignacio Rodriguez-Izquierdo; Rafael Ceña-Diez; Maria Jesús Serramia; Rosa Rodriguez-Fernández; Isidoro Martínez; Mariángeles Muñoz-Fernández
Journal:  Polymers (Basel)       Date:  2021-06-29       Impact factor: 4.329

8.  Capturing respiratory syncytial virus season in Belgium using the influenza severe acute respiratory infection surveillance network, season 2018/19.

Authors:  Lorenzo Subissi; Nathalie Bossuyt; Marijke Reynders; Michèle Gérard; Nicolas Dauby; Marc Bourgeois; Bénédicte Delaere; Sophie Quoilin; Steven Van Gucht; Isabelle Thomas; Cyril Barbezange
Journal:  Euro Surveill       Date:  2020-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.